// App-Quantinova.ai

OT1-2-03 : The DETECT-study concept: Treatment based on the phenotype of circulating tumor cells in HER2-negative metastatic breast cancer

Researchers

Presenter

  • Jaeger BAS

Principal Investigators

  • Albrecht S

  • Schochter FMelcher CAHagenbeck C

  • Friedl TWP

  • Rack B

  • Mller V

  • Fasching PA

  • Janni W

  • Fehm T

Medical Centers

  • University Hospital Med Ctr, Munich, Germany

  • University Hospital Duesseldorf, Duesseldorf, GermanyUniversity Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyUniversity Hospital Hamburg-Eppendorf, Hamburg, Germany

  • University of Ulm, Ulm, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Fluorescein sodium

  • Everolimus

  • Eribulin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved